Velázquez-Martínez CA - Search Results

1

Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo.

Chattopadhyay M, Kodela R, Nath N, Street CR, Velázquez-Martínez CA, Boring D, Kashfi K. Chattopadhyay M, et al. Biochem Pharmacol. 2012 Mar 15;83(6):733-40. doi: 10.1016/j.bcp.2011.12.020. Epub 2011 Dec 24. Biochem Pharmacol. 2012. PMID: 22209714

2

Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.

Chattopadhyay M, Kodela R, Nath N, Dastagirzada YM, Velázquez-Martínez CA, Boring D, Kashfi K. Chattopadhyay M, et al. Biochem Pharmacol. 2012 Mar 15;83(6):715-22. doi: 10.1016/j.bcp.2011.12.018. Epub 2011 Dec 26. Biochem Pharmacol. 2012. PMID: 22222427

3

Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: differences in mode of cyclooxygenase inhibition.

Kodela R, Chattopadhyay M, Goswami S, Gan ZY, Rao PP, Nia KV, Velázquez-Martínez CA, Kashfi K. Kodela R, et al. J Pharmacol Exp Ther. 2013 Apr;345(1):85-94. doi: 10.1124/jpet.112.201970. Epub 2013 Jan 24. J Pharmacol Exp Ther. 2013. PMID: 23349335 Free PMC article.

4

Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling.

Kodela R, Nath N, Chattopadhyay M, Nesbitt DE, Velázquez-Martínez CA, Kashfi K. Kodela R, et al. Drug Des Devel Ther. 2015 Aug 24;9:4873-82. doi: 10.2147/DDDT.S91116. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26346117 Free PMC article.

5

NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications.

Kodela R, Chattopadhyay M, Velázquez-Martínez CA, Kashfi K. Kodela R, et al. Biochem Pharmacol. 2015 Dec 15;98(4):564-72. doi: 10.1016/j.bcp.2015.09.014. Epub 2015 Sep 21. Biochem Pharmacol. 2015. PMID: 26394025 Free PMC article.

6

SP1-independent inhibition of FOXM1 by modified thiazolidinediones.

Tabatabaei Dakhili SA, Pérez DJ, Gopal K, Haque M, Ussher JR, Kashfi K, Velázquez-Martínez CA. Tabatabaei Dakhili SA, et al. Among authors: velazquez martinez ca. Eur J Med Chem. 2021 Jan 1;209:112902. doi: 10.1016/j.ejmech.2020.112902. Epub 2020 Oct 10. Eur J Med Chem. 2021. PMID: 33069434

7

Nitric oxide release is not required to decrease the ulcerogenic profile of nonsteroidal anti-inflammatory drugs.

Jain S, Tran S, El Gendy MA, Kashfi K, Jurasz P, Velázquez-Martínez CA. Jain S, et al. J Med Chem. 2012 Jan 26;55(2):688-96. doi: 10.1021/jm200973j. Epub 2012 Jan 10. J Med Chem. 2012. PMID: 22148253

8

Synthesis and chemical and biological comparison of nitroxyl- and nitric oxide-releasing diazeniumdiolate-based aspirin derivatives.

Basudhar D, Bharadwaj G, Cheng RY, Jain S, Shi S, Heinecke JL, Holland RJ, Ridnour LA, Caceres VM, Spadari-Bratfisch RC, Paolocci N, Velázquez-Martínez CA, Wink DA, Miranda KM. Basudhar D, et al. J Med Chem. 2013 Oct 24;56(20):7804-20. doi: 10.1021/jm400196q. Epub 2013 Oct 8. J Med Chem. 2013. PMID: 24102516 Free PMC article.

9

Resveratrol-salicylate derivatives as selective DNMT3 inhibitors and anticancer agents.

Aldawsari FS, Aguayo-Ortiz R, Kapilashrami K, Yoo J, Luo M, Medina-Franco JL, Velázquez-Martínez CA. Aldawsari FS, et al. J Enzyme Inhib Med Chem. 2016 Oct;31(5):695-703. doi: 10.3109/14756366.2015.1058256. Epub 2015 Jun 29. J Enzyme Inhib Med Chem. 2016. PMID: 26118420 Free PMC article.

10

Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis.

Salla M, Aguayo-Ortiz R, Danmaliki GI, Zare A, Said A, Moore J, Pandya V, Manaloor R, Fong S, Blankstein AR, Gibson SB, Garcia LR, Meier P, Bhullar KS, Hubbard BP, Fiteh Y, Vliagoftis H, Goping IS, Brocks D, Hwang P, Velázquez-Martínez CA, Baksh S. Salla M, et al. Among authors: velazquez martinez ca. J Pharmacol Exp Ther. 2018 May;365(2):354-367. doi: 10.1124/jpet.117.247163. Epub 2018 Mar 19. J Pharmacol Exp Ther. 2018. PMID: 29555876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page